跳至主要内容
临床试验/DRKS00021727
DRKS00021727尚未招募不适用

Incidence and long-term course of subclinical and clinical myocardial damage as well as pulmonary vascular and structural changes in patients with COVID-19

niversitätsherzzentrum Freiburg Bad Krozingen0 个研究点目标入组 100 人开始时间: 2020年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • PCR-secured SARS-CoV-2 infection
  • - Clinically manifest signs of SARS-CoV-2 infection
  • - Ability / willingness to come to the 6-month follow-up

排除标准

  • - Missing written informed consent
  • - Contraindication for MRI examination according to the current guidelines (e.g. metal implants, severe allergy to MRI contrast media)
  • - severe renal failure (creatinine clearance <30ml / min / 1.73m2)
  • - People who are in a dependency or employment relationship with the clinic or examiner stand
  • - Placement in an institution based on a judicial or official order
  • - Demential development or other illness (e.g. substance abuse) that a Understanding of the clarification in the study and / or a legally effective clarification makes unlikely.
  • - pregnancy

研究者

发起方
niversitätsherzzentrum Freiburg Bad Krozingen

相似试验